Clinical Trials · NCT05652205
A Study to Assess Adverse Events and Change in Symptoms With Linaclotide Versus Placebo in Pediatric Subjects, Ages 2 to 5 Years, With Functional Constipation
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- AbbVie
- Enrollment
- 123
- Start date
- Dec 2022
- Locations
- 48 sites, 4 countries
- Primary endpoint
- Change From Baseline in 12-week Spontaneous Bowel Movement (SBM) Frequency Rate (SBMs/Week) Observed by the Primary Caregiver During the Double-blind Study Intervention Period